Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage

NCT01176565 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT01176565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01176565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II: A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage
Lead sponsor
University of Minnesota
Phase
Phase 3
Overall status
Terminated
Start date
May 15, 2011
Completion date
March 8, 2016
Enrollment
1,000 (actual)
Sites
171

Conditions

As the registry lists them; a condition with its own page is linked.

intracerebral hemorrhage